A detailed history of Janus Henderson Group PLC transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 4,558,519 shares of EWTX stock, worth $146 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
4,558,519
Previous 2,607,299 74.84%
Holding current value
$146 Million
Previous $47 Million 159.1%
% of portfolio
0.06%
Previous 0.03%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$15.88 - $29.5 $31 Million - $57.6 Million
1,951,220 Added 74.84%
4,558,519 $122 Million
Q2 2024

Aug 14, 2024

BUY
$15.08 - $21.23 $12.1 Million - $17 Million
801,987 Added 44.42%
2,607,299 $47 Million
Q1 2024

May 15, 2024

BUY
$9.25 - $19.97 $5.46 Million - $11.8 Million
590,299 Added 48.58%
1,805,312 $32.9 Million
Q4 2023

Feb 14, 2024

BUY
$5.51 - $12.1 $519,295 - $1.14 Million
94,246 Added 8.41%
1,215,013 $13.3 Million
Q3 2023

Nov 14, 2023

BUY
$5.73 - $7.69 $3.09 Million - $4.15 Million
540,019 Added 92.99%
1,120,767 $6.42 Million
Q2 2023

Aug 14, 2023

SELL
$5.71 - $10.29 $1.08 Million - $1.95 Million
-189,051 Reduced 24.56%
580,748 $4.5 Million
Q1 2023

May 15, 2023

SELL
$6.66 - $11.33 $4.33 Million - $7.37 Million
-650,070 Reduced 45.78%
769,799 $5.13 Million
Q4 2022

Feb 14, 2023

SELL
$7.58 - $11.08 $933,378 - $1.36 Million
-123,137 Reduced 7.98%
1,419,869 $12.7 Million
Q3 2022

Nov 14, 2022

SELL
$8.08 - $13.58 $536,156 - $901,114
-66,356 Reduced 4.12%
1,543,006 $15.2 Million
Q2 2022

Aug 15, 2022

BUY
$5.67 - $9.87 $998,180 - $1.74 Million
176,046 Added 12.28%
1,609,362 $12.8 Million
Q1 2022

May 16, 2022

SELL
$9.1 - $18.97 $846,472 - $1.76 Million
-93,019 Reduced 6.09%
1,433,316 $13.9 Million
Q4 2021

Feb 14, 2022

SELL
$14.41 - $22.41 $2.96 Million - $4.61 Million
-205,688 Reduced 11.88%
1,526,335 $23.3 Million
Q3 2021

Nov 16, 2021

SELL
$14.11 - $24.1 $807,896 - $1.38 Million
-57,257 Reduced 3.2%
1,732,023 $27.6 Million
Q2 2021

Aug 16, 2021

SELL
$21.33 - $30.25 $7.5 Million - $10.6 Million
-351,628 Reduced 16.42%
1,789,280 $36.7 Million
Q1 2021

May 17, 2021

BUY
$30.0 - $35.99 $64.2 Million - $77.1 Million
2,140,908 New
2,140,908 $65.1 Million

Others Institutions Holding EWTX

About Edgewise Therapeutics, Inc.


  • Ticker EWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 63,171,700
  • Market Cap $2.02B
  • Description
  • Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...
More about EWTX
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.